Expertise at Chang Gung System

Wu, Chih-Ching ,Ph.D.
Institution: Chang Gung University
Position: Associate professor
Department: Department of Medical Biotechnology and Laboratory Science
Address: No.259, Wenhua 1st Rd., Guishan Dist., Taoyuan City 33302, Taiwan
Tel: +886-3-2118800 ext. 5093
E-mail: luckywu@mail.cgu.edu.tw

> Focus of Interest:
  • Biochemistry and Molecular Biology - Medicine
  • Medical Technology, and Clinical Pathology
  • Oncology

Fulltime Employment:
  • 2008-2010 Research assistant professor, Molecular Medicine Research Center, Chang Gung University
  • 2010-2014 Assistant professor, Department of Medical Biotechnolog and Laboratory Science, Chang Gung University
  • 2014-present Associate professor, Department of Medical Biotechnolog and Laboratory Science, Chang Gung University

Education:
  • 1992-1996 B.A. Chang Gung University, Taiwan Medical Technology
  • 1996-1998 MSc. Chang Gung University, Taiwan Tumor immunology
  • 1998-2005 Ph.D. Chang Gung University, Taiwan Biochemistry

Honors and Awards:
  • 2009 HUPO Young Investigator Travel Award
  • 2009 TPS International Proteomics Conference and 5th AOHUPO MPI Workshop Poster Award
  • 2007 AOHUPO/KSMS Young Scientist Award
  • 2004 Chang Gung University Youth Award

Selected Main Publications:
  1. Wang LJ, Hsu CW, Chen CC, Liang Y, Chen LC, Ojcius DM, Tsang NM, Hsueh C, Wu CC#, Chang YS#. Interactome-wide analysis identifies end-binding protein 1 as a crucial component for the speck-like particle formation of activated AIM2 inflammasomes. Mol Cell Proteomics 2012, 11(11), 1230-44. (#corresponding author)
  2. Liu HP*, Wu CC*, Kao HY, Huang YC, Liang Y, Chen CC, Yu JS, Chang YS. Proteome-wide dysregulation by PRA1 depletion delineates a role of PRA1 in lipid transport and cell migration. Mol Cell Proteomics 2011, 10(3), M900641MCP200. (*equal contribution)
  3. Wu CC*, Hsu CW*, Chen CD, Yu CJ, Chang KP, Tai DI, Liu HP, Su WH, Chang YS, Yu JS. Candidate serological biomarkers for cancer identified from the secretomes of 23 cancer cell lines and the human protein atlas. Mol Cell Proteomics 2010, 9(6), 1100-17. (*equal contribution)
  4. Wu CC, Chang YT, Chang KP, Liu YL, Liu HP, Lee IL, Yu JS, Chiang WF. Salivary auto-antibodies as noninvasive diagnostic markers of oral cavity squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 2014, 23(8), 1569-78.
  5. Hsu CW, Yu JS, Peng PH, Liu SC, Chang YS, Chang KP, Wu CC. Secretome profiling of primary cells reveals that THBS2 is a salivary biomarker of oral cavity squamous cell carcinoma. J Proteome Res 2014, 13(11), 4796-807.

 


All Publications List